Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Erapride MV 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Venera Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Erapride MV 2mg/500mg/0.2mg Tablet

Diabetol-Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy manages type 2 diabetes in adults by regulating blood glucose. Diabetol-Trio should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled glucose levels; abrupt cessation can lead to hyperglycemia and potentially serious complications including renal impairment, vision loss, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are key to diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them with readily available glucose. Regular meals and carrying fast-acting glucose sources are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Erapride MV 2mg/500mg/0.2mg Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Erapride MV 2mg/500mg/0.2mg Tablet

Managing Type 2 diabetes

Major Benefits of Erapride MV 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Erapride MV 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

Common Side effects of Erapride MV 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Erapride MV 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Erapride MV 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Erapride MV 2mg/500mg/0.2mg Tablet works:

Each Erapride MV tablet (2mg/500mg/0.2mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Erapride MV 2mg/500mg/0.2mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Erapride MV 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Erapride MV 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney impairment should likely avoid Erapride MV 2mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Erapride MV 2mg/500mg/0.2mg Tablets is contraindicated in individuals with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Erapride MV 2mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. Consult a physician. A low initial dose is typically advised for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Erapride MV 2mg/500mg/0.2mg Tablet :

Should you forget to take your Erapride MV 2mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Erapride MV 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Erapride MV 2mg/500mg/0.2mg Tablet

Erapride MV 2mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is unsuitable for type 1 diabetes.
Erapride MV 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infections.
Erapride MV 2mg/500mg/0.2mg Tablets are contraindicated in patients with allergies to its components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Erapride MV 2mg/500mg/0.2mg tablets is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Erapride MV 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Erapride MV 2mg/500mg/0.2...
104
MRP 120
13% off